{"nct_id":"NCT05590585","title":"Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2023-01-11","start_date_type":"ACTUAL","primary_completion_date":"2024-11-14","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-14","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["REGN"]}